Kahalalide F vs Dolastatin 10
Head-to-head comparison of Kahalalide F (Kahalalide F) and Dolastatin 10 (Dolastatin 10) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Kahalalide F | Dolastatin 10 |
|---|---|---|
| Category | Experimental | Experimental |
| Full Name | Kahalalide F | Dolastatin 10 |
| Molecular Weight | 1111.3 Da | 771.0 Da |
| Half-Life | N/A | N/A |
| Amino Acids | N/A | 5 |
| Typical Dose | 0.1-3 mg/m2 IV in early trials | N/A in humans; subnanomolar to low-nanomolar in vitro |
| Route | Intravenous | Intravenous |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 300 |
| Research Status | Pre-clinical | Pre-clinical |
Kahalalide F Benefits
- ✓antineoplastic
- ✓pro-apoptotic
- ✓membrane-active
- ✓anti-proliferative
Dolastatin 10 Benefits
- ✓antineoplastic
- ✓microtubule disruption
- ✓antimitotic
- ✓ADC payload scaffold
Kahalalide F Dosing
IV infusion in phase I oncology studies|dose escalation used in trials|preclinical nanomolar assays
Dolastatin 10 Dosing
research-grade in vitro nanomolar use|early IV oncology exploration|no approved dosing regimen
Kahalalide F Side Effects
- ⚠fatigue
- ⚠nausea
- ⚠transaminase elevation
Dolastatin 10 Side Effects
- ⚠peripheral neuropathy
- ⚠neutropenia
- ⚠fatigue
Research Overview
Kahalalide F
Kahalalide F was investigated in multiple preclinical and early clinical cancer studies because of its unusual membrane-disrupting and anti-tumor effects. Development highlighted the promise and limits of marine depsipeptides as oncology leads.
Dolastatin 10
Dolastatin 10 became famous for extreme cytotoxic potency and its ability to block tubulin polymerization. Although the native compound itself did not become a standard therapy, it inspired a major class of clinically important auristatin-based payloads.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.